Accrued Expenses

9 Months Ended

Sep. 30, 2022

Accrued Expenses

Accrued Expenses

Note 4. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	September 30,		December 31,
	2022		2021
Clinical trial expenses	$	1,913,221	$	2,625,779
Other		322,230		330,766
Total	$	2,235,451	$	2,956,545